ANXA2 and central nervous system cancer: Moreover, it has recently been reported that ANXA2 should control the invasive properties of glioma cells by a double mechanism consisting of: i) augmented cancer cell binding to endothelial cells that eases the process of vascular co-option; ii) increase of VEGF and PDGF production which induce angiogenesis [59].